Peptides·5000 IU

HCG 5000IU

Human Chorionic Gonadotropin — essential for maintaining testicular function on-cycle and during PCT.

4.7· 267 reviews
Janoshik · Per-batch certificateCOA in commissioning
This SKU's certificate of analysis is in the Janoshik queue. Ships from current inventory; the lab report publishes here as soon as the lab signs it. View the public COA queue →

Compound

5000 IU
In stock

At a glance

At a glance

Concentration
5000 IU
Purity
99.5%+
Route
Subcutaneous injection
Storage
Lyophilized: room temperature, desiccated. Reconstituted: 2–8°C, ≤30 days.

Human Chorionic Gonadotropin (HCG) is a 237-amino-acid heterodimeric glycoprotein hormone composed of an alpha subunit (shared with LH, FSH, and TSH) and a unique beta subunit that confers its biological specificity. HCG is naturally produced by trophoblast cells of the placenta during pregnancy, but its research significance lies in its near-identical structural and functional homology with luteinizing hormone (LH). HCG binds to and activates the LH/CG receptor on Leydig cells in the testes, directly stimulating testosterone biosynthesis through the cholesterol side-chain cleavage pathway, independent of the hypothalamic-pituitary axis.

HCG's mechanism at the testicular level bypasses the HPG axis entirely. By directly binding LH receptors on Leydig cells, it activates adenylyl cyclase, increases cAMP, and upregulates the steroidogenic acute regulatory protein (StAR) that transports cholesterol into mitochondria for conversion to pregnenolone — the rate-limiting step in testosterone synthesis. This direct Leydig cell stimulation maintains intratesticular testosterone (ITT) at levels necessary for spermatogenesis, testicular volume, and Leydig cell viability even when exogenous androgen use has suppressed LH secretion from the pituitary. Without LH receptor stimulation, Leydig cells undergo progressive desensitization and atrophy, making HCG essential for preserving testicular function during protocols that suppress endogenous gonadotropins.

Research consistently demonstrates that HCG maintains testicular size, preserves intratesticular testosterone concentrations, supports spermatogenesis, and facilitates faster recovery of endogenous testosterone production when exogenous androgens are discontinued. It is the standard of care for preventing testicular atrophy during testosterone replacement therapy and is a foundational component of post-cycle therapy (PCT) protocols, where it is typically used as a "bridge" between the cessation of suppressive compounds and the initiation of SERM-based recovery.

HCG is suited for researchers investigating testicular function maintenance, HPG axis recovery, intratesticular testosterone dynamics, and reproductive hormone optimization. It is an essential compound for any research protocol involving suppressive hormonal compounds.

Reconstitute the 5000IU vial with 2.5ml bacteriostatic water (yielding 2000IU/ml). Administer via subcutaneous or intramuscular injection. On-cycle research dosing typically ranges from 250-500IU every other day or twice weekly. PCT bridge dosing may use 1000-1500IU every other day for 2-3 weeks before transitioning to SERMs. HCG has a half-life of approximately 24-36 hours. Store reconstituted solution at 2-8C and use within 30 days — HCG is a large glycoprotein that degrades relatively quickly in solution. Do not freeze reconstituted HCG. The lyophilized powder should be refrigerated.

HCG 5000IU is supplied as a lyophilized (freeze-dried) powder and must be reconstituted with bacteriostatic water (BAC water) before use in a research setting.

  1. Clean the BAC water vial stopper and the peptide vial stopper with an alcohol swab. Allow to dry.
  2. Draw the required volume of BAC water into a sterile syringe (typically 1–3 mL depending on target concentration).
  3. Angle the needle so the water runs down the inside wall of the peptide vial. Avoid dispensing directly onto the powder.
  4. Do not shake. Gently swirl or roll until fully dissolved. Vigorous shaking can denature peptides.
  5. Refrigerate reconstituted solution at 2–8°C. Most reconstituted peptides are stable 14–30 days depending on compound.
Tip

Target concentration determines drawing volume. For dosing math, consult the dosing math guide.

Certificate of Analysis

Independent lab verification

Purity
99.5%+

Research disclaimer

For research and laboratory use only. Not for human or veterinary consumption. Novo Pharma sells to qualified researchers of legal age and ships to Canadian addresses only. See disclaimer and terms.

Read the research

Reference articles from the lab covering this compound.

Related compounds.

View all Peptides